Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
2000
Trial Sponsor
Clinical Trial Start Date
July 20, 2022
0Primary Completion Date
July 20, 2025
0Study Completion Date
December 25, 2025
0Clinical Trial Study Type
Observational0
Intervention Type
Drug0
Intervention Name
Ciclopirox Topical Gel0
Amorolfine 50 MG/ML0
Terbinafine Topical Gel0
Terbinafine 250 mg0
Itraconazole 200 mg0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Prospective0
Official Name
Pilot Study on the Evaluation of the Efficacy, Tolerability and Safety of Topical and Oral Antifungals in the Treatment of Onychomycosis and Creation of a Library of Dermatological Clinical Isolates0
Last Updated
August 1, 2022
0Study summary
This pilot, prospective, observational drug study aims to evaluate the efficacy, tolerability and safety of topical and oral antifungals in the treatment of onychomycosis caused by yeasts, dermatophytic moulds and non-dermatophytic moulds as well as correlate the scores in the MALDI-TOF method for the 'identification of genus and species of higher fungi utilizing the comparison between identification in direct optical microscopy, culture examination and optical microscopy and macroscopic and onychoscopic clinical aspects. Furthermore, an optional substudy will evaluate the drug resistance of clinical isolates using molecular or genetic methods.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
